Effect of Infliximab on Experimentally Induced Otitis Media in Rats

Abstract

Objectives:

We performed a prospective randomized and controlled animal study to investigate the effects of infliximab on experimental otitis media in rats.

Methods:

Seventy-two Sprague-Dawley rats were randomly allocated to 3 study groups and 1 control group. Infliximab was injected intravenously. Histopathologic changes were determined by hematoxylin-eosin staining. Fluorescence microscopy was performed to examine the leakage of the exudates. Vascular permeability was measured by the Evans blue dye technique.

Results:

In comparison with the control group, we found significant differences in the extent of middle ear mucosa without active inflammation and the presence of reparable lesions in all study groups treated with infliximab. A significant reduction of extravasated Evans blue dye in all study group animals was found as compared with the control group animals.

Conclusions:

This study suggests that the monoclonal tumor necrosis factor α antibody, infliximab, can reduce inflammatory activity in experimental otitis media in rats.

Keywords

anti-inflammatory agent infliximab monoclonal antibody otitis media rat tumor necrosis factor α

Get full access to this article

View all access options for this article.

References

Weaver

. Efficacy and safety of the anti-TNF biologic agents. Mod Rheumatol 2004;14:101–12.

Lee

Park

Jung

Yeo

Choi

Jeon

. Effect of tumor necrosis factor–alpha on experimental otitis media with effusion. Laryngoscope 2001;111:728–33.

Jeon

Park

Choi

Yeo

Jung

. Effect of inhibitor of tumor necrosis factor–alpha on experimental otitis media with effusion. Ann Otol Rhinol Laryngol 2001;110:917–21.

Park

Auo

Jeon

Chang

Lee

. Effect of inhibitor of tumor necrosis factor–alpha and oxatomide on immune mediated otitis media. Laryngoscope 2006;116:1642–6.

Kim

Park

Jeon

Yeo

Chang

Lee

. Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. Ann Otol Rhinol Laryngol 2006;115:617–23.

Qaum

Adamis

. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 2001;42:789–94.

Zhang

Sima

. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am J Pathol 2005;166:313–21.

Tomasek

Haaksma

Schwartz

. Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci 2006;47:2693–700.

Schousboe

Ovesen

Pedersen

. Middle ear epithelium has inflammatory capacity. Acta Otolaryngol Suppl 2000;543:89–91.

10.

Lin

Haruta

Kawano

. Induction of mucin gene expression in middle ear of rats by tumor necrosis factor–alpha: Potential cause for mucoid otitis media. J Infect Dis 2000;182:882–7.

11.

Kerschner

Meyer

Burrows

. Chinchilla middle ear epithelial mucin gene expression in response to inflammatory cytokines. Arch Otolaryngol Head Neck Surg 2004;130:1163–7.

12.

Kawano

Haruta

Tsuboi

. Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: The pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol 2002;111:415–22.

13.

Triantafillidis

Papalois

Parasi

. Favorable response to subcutaneous administration of infliximab in rats with experimental colitis. World J Gastroenterol 2005;11:6843–7.